Bernd Engelmann
Overview
Explore the profile of Bernd Engelmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
3196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stark K, Kilani B, Stockhausen S, Busse J, Schubert I, Tran T, et al.
Immunity
. 2024 Sep;
57(9):2140-2156.e10.
PMID: 39226900
Venous thromboembolism (VTE) is a common, deadly disease with an increasing incidence despite preventive efforts. Clinical observations have associated elevated antibody concentrations or antibody-based therapies with thrombotic events. However, how...
2.
Mueller T, Pilartz M, Thakur M, LangHeinrich T, Luo J, Block R, et al.
Haematologica
. 2024 Apr;
109(8):2487-2499.
PMID: 38572559
Innate myeloid cells especially neutrophils and their extracellular traps are known to promote intravascular coagulation and thrombosis formation in infections and various other conditions. Innate myeloid cell-dependent fibrin formation can...
3.
Kaiser R, Gold C, Joppich M, Loew Q, Akhalkatsi A, Mueller T, et al.
Sci Adv
. 2024 Mar;
10(12):eadl1710.
PMID: 38517968
Neutrophils rapidly respond to inflammation and infection, but to which degree their functional trajectories after mobilization from the bone marrow are shaped within the circulation remains vague. Experimental limitations have...
4.
Brandhofer M, Hoffmann A, Blanchet X, Siminkovitch E, Rohlfing A, El Bounkari O, et al.
Cell Mol Life Sci
. 2022 Sep;
79(10):512.
PMID: 36094626
To fulfil its orchestration of immune cell trafficking, a network of chemokines and receptors developed that capitalizes on specificity, redundancy, and functional selectivity. The discovery of heteromeric interactions in the...
5.
Morigny P, Kaltenecker D, Zuber J, Machado J, Mehr L, Tsokanos F, et al.
J Cachexia Sarcopenia Muscle
. 2021 Aug;
12(5):1333-1351.
PMID: 34427055
Background: Cancer cachexia (CCx) is a multifactorial wasting disorder characterized by involuntary loss of body weight that affects many cancer patients and implies a poor prognosis, reducing both tolerance to...
6.
7.
Pircher J, Engelmann B, Massberg S, Schulz C
Thromb Haemost
. 2019 Jun;
119(8):1274-1282.
PMID: 31254975
Atherothrombosis is a frequent cause of cardiovascular mortality. It is mostly triggered by plaque rupture and exposure of the thrombogenic subendothelial matrix, which initiates platelet aggregation and clot formation. Current...
8.
Pfeiler S, Thakur M, Grunauer P, Megens R, Joshi U, Coletti R, et al.
FASEB J
. 2018 Sep;
33(2):1860-1872.
PMID: 30207797
Tumor microvesicles are a peculiar type of extracellular vesicles that circulate in the blood of patients with metastatic cancer. The itineraries and immune cell interactions of tumor microvesicles during the...
9.
Stark K, Schubert I, Joshi U, Kilani B, Hoseinpour P, Thakur M, et al.
Arterioscler Thromb Vasc Biol
. 2018 Feb;
38(4):772-786.
PMID: 29419408
Objective: Cancer patients are at high risk of developing deep venous thrombosis (DVT) and venous thromboembolism, a leading cause of mortality in this population. However, it is largely unclear how...
10.
Pfeiler S, Stark K, Massberg S, Engelmann B
Haematologica
. 2016 Dec;
102(2):206-213.
PMID: 27927771
Neutrophils, early mediators of the innate immune defense, are recruited to developing thrombi in different types of thrombosis. They amplify intravascular coagulation by stimulating the tissue factor-dependent extrinsic pathway via...